Literature DB >> 33417079

Impact of the acquisition protocol on the sensitivity to demyelination and axonal loss of clinically feasible DWI techniques: a simulation study.

Stefania Oliviero1, Cosimo Del Gratta2.   

Abstract

OBJECTIVE: To evaluate: (a) the specific effect that the demyelination and axonal loss have on the DW signal, and (b) the impact of the sequence parameters on the sensitivity to damage of two clinically feasible DWI techniques, i.e. DKI and NODDI.
METHODS: We performed a Monte Carlo simulation of water diffusion inside a novel synthetic model of white matter in the presence of axonal loss and demyelination, with three compartments with permeable boundaries between them. We compared DKI and NODDI in their ability to detect and assess the damage, using several acquisition protocols. We used the F test statistic as an index of the sensitivity for each DWI parameter to axonal loss and demyelination, respectively.
RESULTS: DKI parameters significantly changed with increasing axonal loss, but, in most cases, not with demyelination; all the NODDI parameters showed sensitivity to both the damage processes (at p < 0.01). However, the acquisition protocol strongly affected the sensitivity to damage of both the DKI and NODDI parameters and, especially for NODDI, the parameter absolute values also. DISCUSSION: This work is expected to impact future choices for investigating white matter microstructure in focusing on specific stages of the disease, and for selecting the appropriate experimental framework to obtain optimal data quality given the purpose of the experiment.
© 2021. European Society for Magnetic Resonance in Medicine and Biology (ESMRMB).

Entities:  

Keywords:  Axonal loss; DKI; Demyelination; Monte carlo diffusion simulation; NODDI; g-ratio

Year:  2021        PMID: 33417079     DOI: 10.1007/s10334-020-00899-5

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  87 in total

1.  Regional and global changes in cerebral diffusion with normal aging.

Authors:  A O Nusbaum; C Y Tang; M S Buchsbaum; T C Wei; S W Atlas
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

Review 2.  Future applications of DWI in MS.

Authors:  J A Maldjian; R I Grossman
Journal:  J Neurol Sci       Date:  2001-05-01       Impact factor: 3.181

Review 3.  The basis of anisotropic water diffusion in the nervous system - a technical review.

Authors:  Christian Beaulieu
Journal:  NMR Biomed       Date:  2002 Nov-Dec       Impact factor: 4.044

Review 4.  Principles of diffusion tensor imaging and its applications to basic neuroscience research.

Authors:  Susumu Mori; Jiangyang Zhang
Journal:  Neuron       Date:  2006-09-07       Impact factor: 17.173

Review 5.  Intravoxel incoherent motion imaging using spin echoes.

Authors:  D Le Bihan; R Turner
Journal:  Magn Reson Med       Date:  1991-06       Impact factor: 4.668

6.  Diffusion tensor brain MR imaging in X-linked cerebral adrenoleukodystrophy.

Authors:  R Ito; E R Melhem; S Mori; F S Eichler; G V Raymond; H W Moser
Journal:  Neurology       Date:  2001-02-27       Impact factor: 9.910

Review 7.  Diffusion tensor imaging and beyond.

Authors:  Jacques-Donald Tournier; Susumu Mori; Alexander Leemans
Journal:  Magn Reson Med       Date:  2011-04-05       Impact factor: 4.668

8.  Utility of axial and radial diffusivity from diffusion tensor MRI as markers of neurodegeneration in amyotrophic lateral sclerosis.

Authors:  Nader S Metwalli; Michael Benatar; Govind Nair; Sharon Usher; Xiaoping Hu; John D Carew
Journal:  Brain Res       Date:  2010-06-01       Impact factor: 3.252

9.  Diffusion tensor magnetic resonance imaging in multiple sclerosis.

Authors:  M Filippi; M Cercignani; M Inglese; M A Horsfield; G Comi
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

10.  Regional DTI differences in multiple sclerosis patients.

Authors:  S D Roosendaal; J J G Geurts; H Vrenken; H E Hulst; K S Cover; J A Castelijns; P J W Pouwels; F Barkhof
Journal:  Neuroimage       Date:  2008-11-05       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.